TURKEL CATHERINE C.

Average Profitability
<0.0001%
Insider Buys Quantity
6
Insider Buys Sum
$365,476.44
Insider Sells Quantity
2
Insider Sells Sum
$18,611.70

Insider Activity of TURKEL CATHERINE C.

According to the SEC Form 4 filings, TURKEL CATHERINE C., being in a position of

  1. director at Lexaria Bioscience Corp.,
    оver the last 12 months, has bought 1600 shares for $5,008, and sold 0 shares,
    over all time since 2023-02-09, has bought 3100 shares for $9,275, and sold 0 shares.

The largest purchase of all time was on 2018-09-11 and amounted to 34096 shares of Eledon Pharmaceuticals, Inc. for $155,341.

The largest sale of all time was on 2019-05-20 and amounted to 7623 shares of Eledon Pharmaceuticals, Inc. for $14,953.

Biography of TURKEL CATHERINE C.

No biography is available at this moment.

2024-08-12PurchaseLexaria Bioscience Corp.
LEXX
director
1,600
0.0097%
$3.13$5,008-0.92%
2023-02-09PurchaseLexaria Bioscience Corp.
LEXX
director
1,500
0.0253%
$2.84$4,267-55.56%
2019-05-21SaleEledon Pharmaceuticals, Inc.
ELDN
President
1,914
0.0163%
$1.91$3,658-66.49%
2019-05-20SaleEledon Pharmaceuticals, Inc.
ELDN
President
7,623
0.068%
$1.96$14,953-65.78%
2018-09-12PurchaseEledon Pharmaceuticals, Inc.
ELDN
President
16,632
0.1711%
$5.02$83,476-44.4%
2018-09-11PurchaseEledon Pharmaceuticals, Inc.
ELDN
President
34,096
0.3509%
$4.56$155,341-38.51%
2018-09-05PurchaseEledon Pharmaceuticals, Inc.
ELDN
President
1,610
0.0163%
$3.97$6,385-29.16%
2017-05-10PurchaseEledon Pharmaceuticals, Inc.
ELDN
Chief Development Officer
11,111
0.4869%
$9.99$110,999-20.43%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.